Expensive lifesaving treatments: allocating resources and maximizing access
Abstract Avisar et al. present an exemplary model for outreach aimed at ensuring that a maximum of patients eligible for expensive Hepatitis C (HPC) drugs receive treatment. We enlarge the picture to put their model in the political, economic and regulatory framework for financing and providing thes...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-01-01
|
| Series: | Israel Journal of Health Policy Research |
| Online Access: | http://link.springer.com/article/10.1186/s13584-017-0195-7 |